ERα-Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast Cancer-Reference-Cited by-同舟云学术

ERα-Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast Cancer

Published:2011-07-20 Issue:4 Volume:1 Page:338-351
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discovery

Author:

Miller Todd W.,Balko Justin M.,Fox Emily M.,Ghazoui Zara,Dunbier Anita,Anderson Helen,Dowsett Mitch,Jiang Aixiang,Smith R. Adam,Maira Sauveur-Michel,Manning H. Charles,González-Angulo Ana M.,Mills Gordon B.,Higham Catherine,Chanthaphaychith Siprachanh,Kuba Maria G.,Miller William R.,Shyr Yu,Arteaga Carlos L.

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 284 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK4/6 inhibition augments anti-tumor efficacy of XPO1 inhibitor selinexor in natural killer/T-cell lymphoma;Cancer Letters;2024-08

2. Inactivated cGAS‐STING Signaling Facilitates Endocrine Resistance by Forming a Positive Feedback Loop with AKT Kinase in ER+HER2– Breast Cancer;Advanced Science;2024-07-18

3. PFKFB3 regulates breast cancer tumorigenesis and Fulvestrant sensitivity by affecting ERα stability;Cellular Signalling;2024-07

4. Quantitative characterization of the effects of fulvestrant alone or in combination with taselisib (PI3Kinase inhibitor) on longitudinal tumor growth in patients with estrogen receptor-positive, HER2-negative, PIK3CA-mutant, advanced or metastatic breast cancer;Cancer Chemotherapy and Pharmacology;2024-06-27

5. Gedatolisib shows superior potency and efficacy versus single-node PI3K/AKT/mTOR inhibitors in breast cancer models;npj Breast Cancer;2024-06-05